Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,61325,Aia5,Adjuvant induced arthritis QTL 5,,0.01,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24483076,107857673,Rat,n/a,region,qtl 1000,1598852,Anxrr19,Anxiety related response QTL 19,5.07,,body movement coordination trait (VT:0005424),number of rearing movements in an experimental apparatus (CMO:0001752),10,19402814,64402814,Rat,n/a,region,qtl 1000,631564,Apr3,Acute phase response QTL 3,3.9,,blood interleukin-6 amount (VT:0008595),plasma interleukin-6 level (CMO:0001927),10,16468736,61468736,Rat,n/a,region,qtl 1000,634351,Apr5,Acute phase response QTL 5,6.7,,blood interleukin-6 amount (VT:0008595),plasma interleukin-6 level (CMO:0001927),12,2513442,47513442,Rat,n/a,region,qtl 1000,1554317,Bmd4,Bone mineral density QTL 4,9.4,0.0001,lumbar vertebra mineral mass (VT:0010511),volumetric bone mineral density (CMO:0001553),10,20170031,102897474,Rat,n/a,region,qtl 1000,2300171,Bmd58,Bone mineral density QTL 58,4.9,0.0001,lumbar vertebra mineral mass (VT:0010511),volumetric bone mineral density (CMO:0001553),10,28789280,73789280,Rat,n/a,region,qtl 1000,631554,Bp133,Blood pressure QTL 133,,0.005,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,764421,66221621,Rat,n/a,region,qtl 1000,1298069,Bp168,Blood pressure QTL 168,5.5,,blood pressure trait (VT:0000183),systolic blood pressure (CMO:0000004),10,27237530,101482600,Rat,n/a,region,qtl 1000,1598855,Bp294,Blood pressure QTL 294,3.5,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),12,1,36919844,Rat,n/a,region,qtl 1000,2292441,Bp308,Blood pressure QTL 308,,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,30099909,75099909,Rat,n/a,region,qtl 1000,10402859,Bp381,Blood pressure QTL 381,,0.002,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,30099909,75099909,Rat,n/a,region,qtl 1000,70223,Bp57,Blood pressure QTL 57,5,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,21523906,83549467,Rat,n/a,region,qtl 1000,631542,Bp82,Blood pressure QTL 82,6.8,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,27237530,102427718,Rat,n/a,region,qtl 1000,70188,BpQTLcluster1,Blood pressure QTL cluster 1,4.864,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),1,21523906,90312401,Rat,n/a,region,qtl 1000,70188,BpQTLcluster1,Blood pressure QTL cluster 1,4.864,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,21523906,90312401,Rat,n/a,region,qtl 1000,70188,BpQTLcluster1,Blood pressure QTL cluster 1,4.864,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,21523906,90312401,Rat,n/a,region,qtl 1000,70188,BpQTLcluster1,Blood pressure QTL cluster 1,4.864,,arterial blood pressure trait (VT:2000000),pulse pressure (CMO:0000292),1,21523906,90312401,Rat,n/a,region,qtl 1000,70198,BpQTLcluster9,Blood pressure QTL cluster 9,2.94,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,21523906,90312401,Rat,n/a,region,qtl 1000,2293680,Bss40,Bone structure and strength QTL 40,5.66,0.0001,femur strength trait (VT:0010010),femur total energy absorbed before break (CMO:0001677),10,1,35538813,Rat,n/a,region,qtl 1000,6893352,Bw100,Body weight QTL 100,0.33,0.6,body mass (VT:0001259),body weight (CMO:0000012),1,17121542,62121542,Rat,n/a,region,qtl 1000,6893681,Bw109,Body weight QTL 109,2.3,0.004,body mass (VT:0001259),body weight (CMO:0000012),12,1,23758197,Rat,n/a,region,qtl 1000,7411545,Bw128,Body weight QTL 128,5.2,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),12,150810,45150810,Rat,n/a,region,qtl 1000,1300174,Bw15,Body weight QTL 15,2.93,,body mass (VT:0001259),body weight loss (CMO:0001399),12,1,11765163,Rat,n/a,region,qtl 1000,8694179,Bw150,Body weight QTL 150,2.9,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),12,150810,45150810,Rat,n/a,region,qtl 1000,6893350,Bw99,Body weight QTL 99,0.87,0.16,body mass (VT:0001259),body weight (CMO:0000012),1,17121542,62121542,Rat,n/a,region,qtl 1000,61427,Cia16,Collagen induced arthritis QTL 16,3.2,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,6429075,99492409,Rat,n/a,region,qtl 1000,631267,Cia20,Collagen induced arthritis QTL 20,3.2,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24483076,107857673,Rat,n/a,region,qtl 1000,631268,Cia21,Collagen induced arthritis QTL 21,3.1,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,14827894,107857673,Rat,n/a,region,qtl 1000,1331791,Cm31,Cardiac mass QTL 31,3.84606,,heart mass (VT:0007028),heart wet weight (CMO:0000069),10,23861015,112626471,Rat,n/a,region,qtl 1000,631532,Cm50,Cardiac mass QTL 50,6.6,,heart mass (VT:0007028),calculated heart weight (CMO:0000073),10,18246394,53637634,Rat,n/a,region,qtl 1000,1581516,Cm56,Cardiac mass QTL 56,4.2,0.05,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),12,1,30749723,Rat,n/a,region,qtl 1000,2301967,Cm73,Cardiac mass QTL 73,4.55,,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),10,14827894,92423564,Rat,n/a,region,qtl 1000,10755457,Coatc14,Coat color QTL 14,,0.01759,coat/hair pigmentation trait (VT:0010463),pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812),12,1,23035872,Rat,n/a,region,qtl 1000,70224,Eae3,Experimental allergic encephalomyelitis QTL 3,4.1,,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046),10,27237530,64648311,Rat,n/a,region,qtl 1000,1581497,Esta1,Estrogen-induced thymic atrophy QTL 1,,,thymus mass (VT:0004954),thymus wet weight (CMO:0000855),10,21707766,64648311,Rat,n/a,region,qtl 1000,7411611,Foco17,Food consumption QTL 17,18.7,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),10,1,42669970,Rat,n/a,region,qtl 1000,7411660,Foco28,Food consumption QTL 28,10.9,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,150810,45150810,Rat,n/a,region,qtl 1000,7411586,Foco5,Food consumption QTL 5,5.4,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,150810,45150810,Rat,n/a,region,qtl 1000,7411595,Foco9,Food consumption QTL 9,4,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,150810,45150810,Rat,n/a,region,qtl 1000,2316949,Gluco60,Glucose level QTL 60,3.7,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),10,14827894,110992275,Rat,n/a,region,qtl 1000,634327,Hc4,Hypercalciuria QTL 4,2.4,,urine calcium amount (VT:0002985),urine calcium excretion rate (CMO:0000763),10,1,38594330,Rat,n/a,region,qtl 1000,631660,Hcar1,Hepatocarcinoma resistance QTL 1,3.4,0.0001,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),10,6229289,36185929,Rat,n/a,region,qtl 1000,9590086,Insglur6,Insulin/glucose ratio QTL 6,18.97,0.001,blood insulin amount (VT:0001560),calculated plasma insulin level (CMO:0002170),12,150810,45150810,Rat,n/a,region,qtl 1000,2303575,Insul14,Insulin level QTL 14,4,,blood insulin amount (VT:0001560),blood insulin level (CMO:0000349),12,492578,45492578,Rat,n/a,region,qtl 1000,9589136,Insul27,Insulin level QTL 27,10.46,0.001,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),10,12639513,57639513,Rat,n/a,region,qtl 1000,631531,Iresp2,Immunoglobin response QTL2,6.3,,blood immunoglobulin E amount (VT:0002492),serum total immunoglobulin E level (CMO:0001542),10,22402817,38204229,Rat,n/a,region,qtl 1000,1354587,Kidm21,Kidney mass QTL 21,3.3,,kidney mass (VT:0002707),right kidney wet weight (CMO:0000082),10,15375474,62469074,Rat,n/a,region,qtl 1000,2312418,Kidm41,Kidney mass QTL 41,3.7,0.0001,kidney mass (VT:0002707),single kidney wet weight to body weight ratio (CMO:0000622),12,1,22650917,Rat,n/a,region,qtl 1000,7387292,Kidm42,Kidney mass QTL 42,3.03,0.0004,kidney mass (VT:0002707),left kidney wet weight (CMO:0000083),12,1,38334225,Rat,n/a,region,qtl 1000,10401803,Kidm50,Kidney mass QTL 50,,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),10,1,44902893,Rat,n/a,region,qtl 1000,2303118,Mamtr7,Mammary tumor resistance QTL 7,,0.003,mammary gland integrity trait (VT:0010552),mammary tumor growth rate (CMO:0000344),10,9841807,108540162,Rat,n/a,region,qtl 1000,1600371,Mcs21,Mammary carcinoma susceptibility QTL 21,3,,mammary gland integrity trait (VT:0010552),mammary tumor growth rate (CMO:0000344),10,30021354,54057745,Rat,n/a,region,qtl 1000,7243862,Mcs30,Mammary carcinoma susceptibility QTL 30,8.62,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),12,1258139,10257059,Rat,n/a,region,qtl 1000,2298544,Neuinf9,Neuroinflammation QTL 9,4.6,,nervous system integrity trait (VT:0010566),"spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126)",10,5877536,64401490,Rat,n/a,region,qtl 1000,61354,Pia10,Pristane induced arthritis QTL 10,,0.01,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24483076,107857673,Rat,n/a,region,qtl 1000,634329,Pia15,Pristane induced arthritis QTL 15,3.1,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24884084,47487910,Rat,n/a,region,qtl 1000,737979,Pia22,Pristane induced arthritis QTL 22,53.1,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),12,2475687,47475687,Rat,n/a,region,qtl 1000,2302042,Pia38,Pristane induced arthritis QTL 38,3.5,0.001,blood immunoglobulin amount (VT:0002460),serum immunoglobulin G1 level (CMO:0002115),12,2513442,47513442,Rat,n/a,region,qtl 1000,724556,Pur2,Proteinuria QTL 2,5.5,,urine protein amount (VT:0005160),urine protein level (CMO:0000591),10,22901497,93886300,Rat,n/a,region,qtl 1000,1331762,Rf40,Renal function QTL 40,3.873,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal vascular resistance (CMO:0001900),10,23861015,66539843,Rat,n/a,region,qtl 1000,9590268,Scort13,Serum corticosterone level QTL 13,3.26,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),10,12639513,57639513,Rat,n/a,region,qtl 1000,9590310,Scort19,Serum corticosterone level QTL 19,6.3,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),10,12639513,57639513,Rat,n/a,region,qtl 1000,9590147,Scort7,Serum corticosterone level QTL 7,13.61,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),12,150810,45150810,Rat,n/a,region,qtl 1000,10450854,Stl34,Serum triglyceride level QTL 34,3.5,0.05,blood LDL triglyceride amount (VT:0010699),blood lipoprotein triglyceride level (CMO:0002685),12,1,22853017,Rat,n/a,region,qtl 1000,1578761,Stresp21,Stress response QTL 21,3.3,,thymus mass (VT:0004954),thymus wet weight (CMO:0000855),10,7521450,52521450,Rat,n/a,region,qtl 1000,8662860,Vetf10,Vascular elastic tissue fragility QTL 10,,,artery integrity trait (VT:0010639),number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562),10,6229095,75983805,Rat,n/a,region,qtl